Laminin α2 chain-deficiency is associated with microRNA deregulation in skeletal muscle and plasma

Frontiers in Aging Neuroscience

Volumn 6, Issue JUL, 2014, Pages

  Holmberg, Johan ^a   Alajbegovic, Azra ^a   Gawlik, Kinga Izabela ^a   Elowsson, Linda ^a   Durbeej, Madeleine ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Fibrosis; Inflammation; Laminin; MDC1A; MicroRNA; Muscular dystrophy

Indexed keywords

BORTEZOMIB; LAMININ ALPHA2; MICRORNA; MICRORNA 1; MICRORNA 133A; MICRORNA 206; MICRORNA 21; MICRORNA 223; PROTEASOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CELL INFILTRATION; CONGENITAL MUSCULAR DYSTROPHY TYPE 1A; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; GENETIC ASSOCIATION; IMMUNOCOMPETENT CELL; MOUSE; MUSCLE LEVEL; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; MYOFIBROSIS; NONHUMAN; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PROTEIN DEFICIENCY; QUADRICEPS FEMORIS MUSCLE; QUANTITATIVE ANALYSIS;

EID: 84904687690     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00155     Document Type: Article

References (39)

1. Ardite, E., Perdiguero, E., Vidal, B., Gutarra, S., Serrano, A. L., and Munoz-Canoves, P. (2012). PAI-1-regulated miR-21 defines a novel age-associated fibrogenic pathway in muscular dystrophy. J. Cell Biol. 196, 163-175. doi: 10.1083/jcb.201105013
2. Bernasconi, P., Di Blasi, C., Mora, M., Morandi, L., Galbiati, S., Confalonieri, P., et al. (1999). Transforming growth factor-beta1 and fibrosis in congenital muscular dystrophies. Neuromuscul. Disord. 9, 28-33. doi:10.1016/S0960-8966(98)00093-5
3. Bernasconi, P., Torchiana, E., Confalonieri, P., Brugnoni, R., Barresi, R., Mora, M., et al. (1995). Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. J. Clin. Invest. 96, 1137-1144. doi:10.1172/JCI118101
4. Cacchiarelli, D., Legnini, I., Martone, J., Cazzella, V., D'Amico, A., Bertini, E., et al. (2011). miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol. Med. 3, 258-265. doi:10.1002/emmm.201100133
5. Cacchiarelli, D., Martone, J., Girardi, E., Cesana, M., Incitti, T., Morlando, M., et al. (2010). microRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab. 12, 341-351. doi:10.1016/j.cmet.2010.07.008
6. Carmignac, V., Quere, R., and Durbeej, M. (2011). Proteasome inhibition improves the muscle of laminin alpha2 chain-deficient mice. Hum. Mol. Genet. 20, 541-552. doi:10.1093/hmg/ddq499
7. Chen, J. F., Mandel, E. M., Thomson, J. M., Wu, Q., Callis, T. E., Hammond, S. M., et al. (2006). The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38, 228-233. doi:10.1038/ng1725
8. Chen, K., and Rajewsky, N. (2007). The evolution of gene regulation by transcription factors and microRNAs. Nat. Rev. Genet. 8, 93-103. doi:10.1038/nrg1990
9. Cohn, R. D., and Campbell, K. P. (2000). Molecular basis of muscular dystrophies. Muscle Nerve 23, 1456-1471. doi:10.1002/1097-4598(200010)23:10 1456::AID-MUS2 3.0.CO;2-T
10. De Guire, V., Robitaille, R., Tetreault, N., Guerin, R., Menard, C., Bambace, N., et al. (2013). Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges. Clin. Biochem. 46, 846-860. doi:10.1016/j.clinbiochem.2013.03.015
11. Ehrig, K., Leivo, I., Argraves, W. S., Ruoslahti, E., and Engvall, E. (1990). Merosin, a tissue-specific basement membrane protein, is a laminin-like protein. Proc. Natl. Acad. Sci. U.S.A. 87, 3264-3268. doi:10.1073/pnas.87.9.3264
12. Eisenberg, I., Eran, A., Nishino, I., Moggio, M., Lamperti, C., Amato, A. A., et al. (2007). Distinctive patterns of microRNA expression in primary muscular disorders. Proc. Natl. Acad. Sci. U.S.A. 104, 17016-17021. doi:10.1073/pnas.0708115104
13. Elbaz, M., Yanay, N., Aga-Mizrachi, S., Brunschwig, Z., Kassis, I., Ettinger, K., et al. (2012). Losartan, a therapeutic candidate in congenital muscular dystrophy: studies in the dy(2J)/dy(2J) mouse. Ann. Neurol. 71, 699-708. doi:10.1002/ana.22694
14. Ervasti, J. M., and Campbell, K. P. (1993). A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122, 809-823. doi:10.1083/jcb.122.4.809
15. Farini, A., Meregalli, M., Belicchi, M., Battistelli, M., Parolini, D., D'Antona, G., et al. (2007). T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse. J. Pathol. 213, 229-238. doi:10.1002/path.2213
16. Gawlik, K. I., Holmberg, J., and Durbeej, M. (2014). Loss of dystrophin and beta-sarcoglycan, respectively, significantly exacerbates the phenotype of laminin alpha2 chain-deficient animals. Am. J. Pathol. 184, 740-752. doi:10.1016/j.ajpath.2013.11.017
17. Gebert, L. F., Rebhan, M. A., Crivelli, S. E., Denzler, R., Stoffel, M., and Hall, J. (2014). Miravirsen (SPC3649) can inhibit the biogenesis of miR-122. Nucleic Acids Res. 42, 609-621. doi:10.1093/nar/gkt852
18. Greco, S., De Simone, M., Colussi, C., Zaccagnini, G., Fasanaro, P., Pescatori, M., et al. (2009). Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J. 23, 3335-3346. doi:10.1096/fj.08-128579
19. Johnnidis, J. B., Harris, M. H., Wheeler, R. T., Stehling-Sun, S., Lam, M. H., Kirak, O., et al. (2008). Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451, 1125-1129. doi:10.1038/nature06607
20. Körner, Z., Holmberg, J., Fontes-Oliveira, C. C., Carmignac, V., and Durbeej, M. (2014). Bortezomib partially improves laminin a2 chain-deficient muscular dystrophy. Am. J. Pathol. 184, 1518-1528. doi:10.1016/j.ajpath.2014.01.019
21. Liu, N., Bezprozvannaya, S., Shelton, J. M., Frisard, M. I., Hulver, M. W., McMillan, R. P., et al. (2011). Mice lacking microRNA 133a develop dynamin 2-dependent centronuclear myopathy. J. Clin. Invest. 121, 3258-3268. doi:10.1172/JCI46267
22. Liu, N., Williams, A. H., Maxeiner, J. M., Bezprozvannaya, S., Shelton, J. M., Richardson, J. A., et al. (2012). microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J. Clin. Invest. 122, 2054-2065. doi:10.1172/JCI62656
23. Mann, C. J., Perdiguero, E., Kharraz, Y., Aguilar, S., Pessina, P., Serrano, A. L., et al. (2011). Aberrant repair and fibrosis development in skeletal muscle. Skelet. Muscle 1, 21. doi:10.1186/2044-5040-1-21
24. Meinen, S., Lin, S., and Ruegg, M. A. (2012). Angiotensin II type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-alpha2-deficient congenital muscular dystrophy (MDC1A). Skelet. Muscle 2, 18. doi:10.1186/2044-5040-2-18
25. Miyagoe, Y., Hanaoka, K., Nonaka, I., Hayasaka, M., Nabeshima, Y., Arahata, K., et al. (1997). Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy. FEBS Lett. 415, 33-39. doi:10.1016/S0014-5793(97)01007-7
26. Mizuno, H., Nakamura, A., Aoki, Y., Ito, N., Kishi, S., Yamamoto, K., et al. (2011). Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PLoS ONE 6:e18388. doi:10.1371/journal.pone.0018388
27. Morrison, J., Lu, Q. L., Pastoret, C., Partridge, T., and Bou-Gharios, G. (2000). T-cell-dependent fibrosis in the mdx dystrophic mouse. Lab. Invest. 80, 881-891. doi:10.1038/labinvest.3780092
28. Neuman, R. E., and Logan, M. A. (1950). The determination of hydroxyproline. J. Biol. Chem. 184, 299-306.
29. Pegoraro, E., Mancias, P., Swerdlow, S. H., Raikow, R. B., Garcia, C., Marks, H., et al. (1996). Congenital muscular dystrophy with primary laminin alpha2 (merosin) deficiency presenting as inflammatory myopathy. Ann. Neurol. 40, 782-791. doi:10.1002/ana.410400515
30. Roberts, T. C., Blomberg, K. E., McClorey, G., Andaloussi, S. E., Godfrey, C., Betts, C., et al. (2012). Expression analysis in multiple muscle groups and serum reveals complexity in the microRNA transcriptome of the mdx mouse with implications for therapy. Mol. Ther. Nucleic Acids 1, e39. doi:10.1038/mtna.2012.26
31. Roberts, T. C., Godfrey, C., McClorey, G., Vader, P., Briggs, D., Gardiner, C., et al. (2013). Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover. Nucleic Acids Res. 41, 9500-9513. doi:10.1093/nar/gkt724
32. Straub, V., Rafael, J. A., Chamberlain, J. S., and Campbell, K. P. (1997). Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J. Cell Biol. 139, 375-385. doi:10.1083/jcb.139.2.375
33. Sunada, Y., Bernier, S. M., Utani, A., Yamada, Y., and Campbell, K. P. (1995). Identification of a novel mutant transcript of laminin alpha 2 chain gene responsible for muscular dystrophy and dysmyelination in dy2J mice. Hum. Mol. Genet. 4, 1055-1061. doi:10.1093/hmg/4.6.1055
34. Tome, F. M., Evangelista, T., Leclerc, A., Sunada, Y., Manole, E., Estournet, B., et al. (1994). Congenital muscular dystrophy with merosin deficiency. C. R. Acad. Sci. III, Sci. Vie 317, 351-357.
35. Vignier, N., Amor, F., Fogel, P., Duvallet, A., Poupiot, J., Charrier, S., et al. (2013). Distinctive serum miRNA profile in mouse models of striated muscular pathologies. PLoS ONE 8:e55281. doi:10.1371/journal.pone.0055281
36. Wang, L., Zhou, L., Jiang, P., Lu, L., Chen, X., Lan, H., et al. (2012). Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis. Mol. Ther. 20, 1222-1233. doi:10.1038/mt.2012.35
37. Xu, H., Wu, X. R., Wewer, U. M., and Engvall, E. (1994). Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene. Nat. Genet. 8, 297-302. doi:10.1038/ng1194-297
38. Yuasa, K., Hagiwara, Y., Ando, M., Nakamura, A., Takeda, S., and Hijikata, T. (2008). microRNA-206 is highly expressed in newly formed muscle fibers: implications regarding potential for muscle regeneration and maturation in muscular dystrophy. Cell Struct. Funct. 33, 163-169. doi:10.1247/csf.08022
39. Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., von Drehle, M., Muth, A. N., et al. (2007). Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129, 303-317. doi:10.1016/j.cell.2007.03.030